Intervention 139 159 6
amlodipine camsylate
Intervention 167 186 6
amlodipine besylate
Intervention 252 271 4
Amlodipine besylate
Intervention 393 413 4
Amlodipine camsylate
Intervention 740 760 5
amlodipine camsylate
Intervention 765 784 5
amlodipine besylate
Intervention 896 916 9
amlodipine camsylate
Intervention 931 950 9
amlodipine besylate
Intervention 1604 1794 8
After 4 weeks, if either blood pressure was > or =140/ > or =90 mm Hg or SiDBP had not decreased by > or =10 mm Hg from baseline, the dose of amlodipine was increased to 10 mg QD for 4 weeks
Intervention 1796 2014 3
Trough blood pressure and heart rate were measured in duplicate with the patient in the sitting position at each clinic visit (baseline [week 0] and weeks 4 and 8 of treatment); mean values were calculated and recorded
Intervention 2016 2151 3
At weeks 4 and 8, tolerability was assessed using history taking and laboratory analysis, and compliance was assessed using pill counts
Intervention 2966 2986 3
amlodipine camsylate
Intervention 3392 3411 3
amlodipine besylate
Intervention 3879 3899 3
amlodipine camsylate
Intervention 3909 3928 3
amlodipine besylate
Intervention 4044 4064 5
amlodipine camsylate
Intervention 4069 4088 5
amlodipine besylate
Intervention 4154 4174 3
amlodipine camsylate
Intervention 4222 4241 3
amlodipine besylate
